
been carried out since the pioneering work. Magnetic
particles of different size (diameters ranging from the
so-called multidomain state down to the superpara-
magnetic region) and different material (magnetite,
maghemite, magnetic glass-ceramic, Ba–Co–ferrite,
etc.) have been tested. The particles are covered or
composed with different organic material or used in
the bare state. Reviews of the results (Jordan et al.
1993, 1999, Hergt et al. 1998, Andra
¨
1998) show that
clinical application cannot yet be applied and several
essential problems are still to be solved.
3.4 Magnetic Targeting of Drugs and
Radiation Sources
Magnetic drug targeting, i.e., guidance and retention
of drug-carrying magnetic particles by means of ex-
ternally applied magnetic fields, has been investigated
since the 1970s. The first clinical experiences with hu-
man patients were reported by Kuznetsov et al.(1997)
who used Fe–C particles combined with anticancer
drugs. Lu
¨
bbe and Bergemann (1997) used magnetic
carriers of multidomain particles of Fe
3
O
4
coated with
starch derivatives and loaded with epirubicin. A con-
centration of the particles was achieved by means of
suitably arranged permanent magnets outside the
body of the patient. Magnetic drug targeting may al-
so be used for the localized treatment of thrombosis,
as demonstrated by Inada et al.(1987)whoperformed
in vitro experiments with magnetic enzyme particles
consisting of magnetite and polyethylene glucol cou-
pled to urokinase. A further kind of magnetic target-
ing is the application of particles for the transport of
radioisotopes, e.g.,
90
Y, to the region where the radi-
ation is to be applied. This novel technique was tested
in animal experiments by Ha
¨
feli et al. (1997) who used
microspheres (10–30 mm in diameter) consisting of a
mixture of polylactic acid and magnetite.
3.5 Magnetic Cell Separation
An already commercially introduced technology is
the selective cell separation by means of polymer
spheres containing small magnetic particles, so-called
magnetic beads. The surface of the beads is coated
with different kinds of monoclonal antibodies de-
signed for special selective binding with appropriately
prepared biological objects. In this way blood cells,
bacteria, or even specific nucleic acid sequences can
be isolated and manipulated in special magnetic sep-
aration equipment. The magnetic component of the
beads in most cases is magnetite. A review of this field
can be found in Ugelstad et al. (1997).
See also: DNA Microarrays Using Magnetic Label-
ing and Detection; MRI Contrast Agents; Permanent
Magnetic Devices in Otiatria; SQUIDs: Biomedical
Applications
Bibliography
Andra
¨
W 1998 Magnetic hyperthermia. In: Andra
¨
W, Nowak H
(eds.) Magnetism in Medicine. Wiley-VCH, Berlin
Andra
¨
W, Danan H, Kirme W, Kramer H-H, Saupe P,
Schmieg R, Bellemann M 2000 A novel method for real time
magnetic marker monitoring in the gastrointestinal tract.
Phys. Med. Biol. 45, 3081–93
Boudghe
`
ne F P, Bach-Gansmo T, Grange J -D, Lame S,
Nantois C, Wallays C, Bigot J-M 1993 Contributions of oral
magnetic particles in MR imaging of the abdomen with spin-
echo and gradient-echo sequences. JMRI 3, 107–12
Burton C, Hill M, Walker E 1971 The RF thermoseed—a
thermally self-regulating implant for the production of brain
lesions. IEEE Biomed. Eng. BME-18, 104–9
Cetas T C, Gross E J, Contractor Y 1998 A ferrite core/metallic
sheath thermoseed for interstitial thermal therapies. IEEE
Trans. Biomed. Eng. 45, 68–77
Fahlenbrach B, Fahlenbrach H 1970 Der Magnetismus in
Medizin und Biologie. Umschau 14, 429–33
Forsman M 1998 Magnetism in gastroenterology. In: Andra
¨
W,
Nowak H (eds.) Magnetism in Medicine. Wiley-VCH, Berlin
Frei E H, Driller J, Neufeld H N, Barr I, Bleiden L, Askenazy H
M 1966 The POD and its applications. Med. Res. Eng. 5, 11–8
Frei E H, Gunders E, Pajewsky M, Alkan W J, Eshchar J 1968
Ferrites as contrast material for medical X-ray diagnosis. J.
Appl. Phys. 39, 999–1001
Gilchrist R K, Medal R, Shorey W D, Hanselman R C, Parrott
J C, Taylor C B 1957 Selective inductive heating of lymph
nodes. Ann. Surgery 146, 596–606
Grady M S, Howard III M A, Molloy J A, Ritter R C, Quate E
G, Gillies G T 1990 Nonlinear magnetic stereotaxis: three-
dimensional, in vivo remote magnetic manipulation of a small
object in canine brain. Med. Phys. 17, 405–15
Gro
¨
ning R, Werner M, Berntgen M, Georgaratis M 1996 Per-
oral controlled release dosage forms with internal magnets
and extracorporal magnetic guidance—investigations into
the renal elimination of riboflavin. Eur. J. Pharm. Biopharm.
42, 25–8
Ha
¨
feli U 1998 The history of magnetism in medicine. In: Andra
¨
W, Nowak H (eds.) Magnetism in Medicine. Wiley-VCH,
Berlin
Ha
¨
feli U, Pauer G, Macklis R M 1997 Magnetically targeted
microspheres for intracavity and intraspinal Y-90 radiother-
apy. In: Ha
¨
feli U, Schu
¨
tt W, Teller J, Zborowsky M (eds.)
Scientific and Clinical Applications of Magnetic Carriers. Ple-
num, New York
Hergt R, Andra
¨
W, d’Ambly C-G, Hilger I, Kaiser W A,
Richter U, Schmidt H-G 1998 Physical limits of hyper-
thermia using magnetite fine particles. IEEE Trans. Magn.
34, 3745–54
Hirschberg J 1899 Geschichte der Augenheilkunde Engelmann,
Leipzig, Vol. 12
Inada Y, Ohwada K, Yoshimoto T, Kojima S, Takahashi K,
Kodera Y, Matsushima A, Saito Y 1987 Fibrinolysis by
urokinase endowed with magnetic property. Biochem. Bio-
phys. Res. Commun. 148, 392–6
Jordan A, Scholz R, Wust P, Fa
¨
hling H, Felix R 1999 Magnetic
fluid hyperthermia (MHF): cancer treatment with AC mag-
netic field induced excitation of biocompatible superpara-
magnetic nanoparticles. J. Magn. Magn. Mater. 201, 413–9
Jordan A, Wust P, Fa
¨
hling H, John W, Hinz A, Felix R 1993
Inductive heating of ferrimagnetic particles and magnetic
fluids: physical evaluation of their potential for hype-
rthermia. Int. J. Hyperthermia 9, 51–68
857
Magnets: Biomedical Applications